Published in Trans Am Clin Climatol Assoc on January 01, 1986
[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications]. Herzschrittmacherther Elektrophysiol (2010) 0.75
Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J Pharmacol Exp Ther (1975) 5.07
Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res (1983) 2.12
Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction. Circulation (1980) 1.43
Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol (1985) 1.19
Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiovasc Res (1983) 1.08
Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol (1983) 0.99
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals. J Clin Invest (1984) 0.93
New antiarrhythmic drugs: their place in therapy. Drugs (1981) 0.87
Disopyramide. Ann N Y Acad Sci (1984) 0.81
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
An artificial standard for use in the estimation of haemoglobin. Biochem J (1945) 6.45
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 3.32
Ultrasonic cardiac echography for determining stroke volume and valvular regurgitation. Circulation (1970) 3.22
Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med (1974) 2.89
Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med (1967) 2.41
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation (1974) 2.16
Ultrasound for the diagnosis of atrial tumor. Ann Intern Med (1969) 2.16
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
Propranolol in patients with angina pectoris. Ann Intern Med (1967) 1.90
Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation (1971) 1.88
The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods (2000) 1.70
Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience (2001) 1.69
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Patients admitted to the coronary care unit for chest pain: high risk subgroup for subsequent cardiovascular death. Am J Cardiol (1977) 1.62
Cytochrome c as a carrier with the glucose dehydrogenase system. Biochem J (1939) 1.54
Saphenous vein coronary artery bypass in patients with "preinfarction angina". Circulation (1973) 1.52
Should lidocaine be administered routinely to all patients after acute myocardial infarction? Circulation (1978) 1.52
Valve replacement in active bacterial endocarditis. N Engl J Med (1967) 1.50
Echocardiographic features of primary pulmonary hypertension. Am J Cardiol (1974) 1.49
Role of concentration-dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm (1979) 1.49
Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol (1972) 1.45
Effect of transducer placement on echocardiographic measurement of left ventricular dimensions. Am J Cardiol (1975) 1.44
Results of direct coronary-artery surgery for the treatment of angina pectoris. N Engl J Med (1973) 1.44
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev (2001) 1.43
Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging (1994) 1.42
Echocardiographic findings in discrete subvalvular aortic stenosis. Circulation (1974) 1.38
Changes in diastolic stiffness and tone of the left ventricle during angina pectoris. Circulation (1974) 1.37
Aortic valve replacement with and without coronary artery bypass surgery. Circulation (1974) 1.37
Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man. Res Commun Chem Pathol Pharmacol (1976) 1.36
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. Br Heart J (1975) 1.35
Long-term tocainide therapy for ventricular arrhythmias. Circulation (1978) 1.35
Vitamin D in ergot of rye. Biochem J (1929) 1.34
Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest (1976) 1.31
Verapamil disposition kinetics in chronic atrial fibrillation. Clin Pharmacol Ther (1981) 1.31
Cardiac transplantation in man. Review of first three years' experience. Am J Med (1973) 1.30
Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept (2002) 1.28
Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram. Am J Cardiol (1979) 1.27
Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J (1981) 1.27
A new catheter system for coronary angioplasty. Am J Cardiol (1982) 1.26
Comparison of dobutamine and dopamine in treatment of severe heart failure. Br Heart J (1977) 1.25
Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol. Circulation (1968) 1.25
Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation (1975) 1.22
Arrhythmias after cardiac transplantation. Am J Cardiol (1974) 1.21
Propranolol in the treatment and prevention of cardiac arrhythmias. Ann Intern Med (1967) 1.20
High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite. J Chromatogr (1977) 1.20
Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med (1976) 1.20
Clinical pharmacology of propafenone. Circulation (1983) 1.19
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J (1983) 1.19
Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol (1985) 1.19
Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol (1977) 1.18
Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol (1971) 1.18
Influence of potassium depletion on myocardial concentration of tritiated digoxin. Circ Res (1967) 1.17
An improved method for echographic detection of left atrial enlargement. Circulation (1974) 1.15
Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide. Circulation (1976) 1.15
Acute haemodynamic effects of practolol in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J (1973) 1.13
The use of central venous oxygen sturation measurements in a coronary care unit. Ann Intern Med (1968) 1.12
Effect of digoxin on atioventricular conduction. Studies in patients with and without cardiac autonomic innervation. Circulation (1975) 1.11
Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis. Circulation (1969) 1.10
Measurement of central venous oxygen saturation in patients with myocarial infarction. Circulation (1968) 1.10
Echocardiographic abnormalities in the mitral valve prolapse syndrome. Circulation (1974) 1.09
The effect of propranolol on exercise-induced ischemic S-T segment depression. Am J Cardiol (1969) 1.09
The relation between myocardial 3 H-digoxin concentration and its hemodynamic effects. Am J Cardiol (1972) 1.08
Histamine and the human heart: the other receptor system. Am J Cardiol (1982) 1.07
Calcium overload, "injury" current, and early ischaemic cardiac arrhythmias--a direct connection. Lancet (1983) 1.07
Prolongation of verapamil elimination kinetics during chronic oral administration. Am Heart J (1982) 1.07
The inotropic effects of digoxin in hyperkalemia. Relation to (Na+,K+)-ATPase inhibition in the intact animal. Circulation (1973) 1.07
Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol (1979) 1.07
Coronary artery spasm--pathophysiology, clinical presentations, diagnostic approaches and rational treatment. West J Med (1982) 1.07
Arrhythmias in patients with mitral valve prolapse. Circulation (1975) 1.06
Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists. Chest (1980) 1.06
Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol (1982) 1.05
Prinzmetal's variant of angina pectoris with only slight coronary atherosclerosis. Calif Med (1968) 1.05
Surgical management of life-threatening ventricular arrhythmias in patients with coronary artery disease. Circulation (1977) 1.05
Valvular-ventricular interaction: importance of the mitral apparatus in canine left ventricular systolic performance. Circulation (1986) 1.05
Autonomic nervous system and arrhythmias: studies in the transplanted denervated human heart. Cardiology (1976) 1.04
Mannose as a possible precursor of ascorbic acid in the tissues of the rat. Biochem J (1937) 1.04
Hemodynamic effects of morphine and pentazocine differ in cardiac patients. N Engl J Med (1972) 1.03
Light-pen computer processing of video image for the determination of left ventricular volume. Circulation (1973) 1.03
The expression of GABA(B1) and GABA(B2) receptor subunits in the cNS differs from that in peripheral tissues. Neuroscience (2000) 1.03
A new look at an old problem: mushroom poisoning. Clinical presentations and new therapeutic approaches. Am J Med (1975) 1.03
Electrophysiologic studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propranolol. Am J Cardiol (1975) 1.02
The clinical spectrum of papillary-muscle disease. N Engl J Med (1969) 1.02
Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation (1974) 1.02
Acute rejection in the long-term cardiac transplant survivor. Clinical diagnosis, treatment and significance. Circulation (1974) 1.01
Diagnosis of left atrial myxoma by echocardiography. N Engl J Med (1970) 1.01
Histamine receptors in the human heart. Life Sci (1980) 1.00
Electrophysiological studies in the denervated transplanted human heart. Response to trial pacing and atropine. Circ Res (1973) 1.00
Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease. Am J Cardiol (1972) 0.99
Editorial: Discontinuation of propranolol therapy. Cause of rebound angina pectoris and acute coronary events. Chest (1976) 0.99
Acebutolol disposition after intravenous administration. Clin Pharmacol Ther (1977) 0.99
Evaluation of the pulse-contour method of determining stroke volume in man. Circulation (1972) 0.98
Mitral valve replacement with the glutaraldehyde-preserved porcine heterograft. Clinical, hemodynamic, and pathological correlations. J Thorac Cardiovasc Surg (1974) 0.98
Coronary hemodynamics during percutaneous transluminal coronary angioplasty. Am J Cardiol (1982) 0.98
Computer measurement of cardiac output by dye dilution: comparison of computer, Fick, and Dow techniques. Cardiovasc Res (1972) 0.97
An electrooptical monitoring technique for heart cells in tissue culture. J Appl Physiol (1970) 0.97
The status of cardiac transplantation, 1975. Circulation (1975) 0.97